Insider buying last 90 days
No open-market insider purchases were filed for DOX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every DOX insider filing, plotted on the chart in Gekko.Open DOX in Gekko
NASDAQ: DOX
Amdocs (DOX) Stock Analysis & Forecast
Sep 28 close
$57.42−0.29 (−0.5%)
Gekko Brief
AI summaryAmdocs shares have traded under pressure, with the stock recently changing hands near USD 59.50 and lagging the broader market over the past six months by a wide margin, a performance gap noted alongside continued discussion of the company's valuation. Separately, Amdocs has been highlighted as a long-term value name. Underlying the commentary is the company's ongoing shift under CEO Shimie Hortig toward agentic automation, including its aOS platform for telecom, a theme management outlined following the last earnings call.
DOX closed at $57.42, down 0.5%, sitting below both its 50-day average of $58.63 and its 200-day average of $65.11, with the shorter average also below the longer one, reflecting a downward trend across the one-month, three-month and one-year windows, though the three-month return is positive at 11.6%. The GekkoIndex reading of 65.1 places the stock in the Accumulation zone. Fair value work puts Gekko Fair Value at $80.79, leaving price 28.9% below that mark.
The next earnings report is scheduled for 10 November 2026, after the close, which falls outside the next 20 trading days. No insider, Congress or unusual options activity appears in the current window. Seasonality over the past 5 years shows the next 20 trading days averaging a 2.1% return, higher in 4 of those years, a pattern worth noting alongside the earnings date sitting just beyond this stretch.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Amdocs price vs fair value
Close $57.42200-day averageGekko Fair Value $80.79
Amdocs quick facts
- Market cap
- $6.18B
- P/E ratio
- 13.7
- Forward P/E
- 7.1
- EPS, TTM
- $4.21
- Revenue, TTM
- $4.65B
- Profit margin
- 9.8%
- Dividend yield
- 3.94%
- Beta
- 0.43
- Volume
- 700,779 avg 884,093
- 1-year return
- −29.3%
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±4.1%
- 50-day average
- $58.63
- 200-day average
- $65.11
- Next earnings
- Nov 10 after close
- Shares outstanding
- 104.4M
Amdocs swing-trade checklist
Amdocs scores 4 supportive, 0 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive0 mixed1 headwind
- Trendheadwind
Below 50 and 200-day
Close $57.42 is below the 50-day ($58.63) and 200-day ($65.11) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
65.1, Accumulation
Reading 65.1 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
28.9% below
Price is 28.9% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 42 days
Next report Nov 10, 2026, 42 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+2.1% on average
From this point in the calendar, the next 20 trading days averaged +2.1% over 5 years, rising in 4 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Amdocs stock chart and price history
Amdocs closed at $57.42 on Sep 28, 2026, −29.3% over the past year, inside a 52-week range of $49.74 to $85.63.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −8.4%
- 3 months
- +11.6%
- 6 months
- −10.7%
- 1 year
- −29.3%
The full DOX chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open DOX in Gekko
Follow Amdocs through every session
Put DOX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track DOX in GekkoFree for 7 days. No credit card required.
About Amdocs
Amdocs designs cloud-based software that helps service providers manage how they build, deliver and bill for their offerings. One of its best-known products, CES21, gives providers a way to shape customer experiences using 5G and cloud-native microservices technology, so they can launch and profit from newer kinds of services. Its catalog also includes tools for handling orders and customer interactions, systems for charging and revenue management, a suite for automating network operations, a cloud-native platform called MarketONE, a package aimed at smaller or emerging telecom brands, and software for managing eSIMs, along with AI-based home operating systems and data intelligence tools.
The company also supplies services that support providers throughout their operations, from initial design and integration to consulting, mobile network work and content-related tasks. A separate managed services offering covers building, updating and maintaining applications, along with IT support, testing and other professional work, aimed at helping clients run and maintain their technology systems. Its customer base includes companies in communications, cable, satellite, entertainment and media, as well as mobile virtual network operators and directory publishers.
Amdocs traces its founding to 1988 and is headquartered in Saint Louis, Missouri. Its stock trades on the NASDAQ under the ticker DOX.
- Listed
- NASDAQ
- Sector
- Technology services
- Industry
- Information technology services
- Website
- amdocs.com
Amdocs GekkoIndex: the smart money zone
Amdocs’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 65.1, in the Accumulation zone, up 4.2 points over five sessions.
65.1Accumulation
Up 4.2 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 54 | −0.8% | −1.0% | ||
| Accumulation (current zone) | 246 | −0.3% | −0.7% | ||
| Neutral | 354 | −0.1% | −1.2% | ||
| Distribution | 16 | −3.5% | −2.8% | ||
| Selling | 2 | Too few readings yet | |||
Average DOX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the DOX price, zone by zone.Track DOX in Gekko
Is Amdocs stock overvalued? Gekko Fair Value
Amdocs trades 28.9% below Gekko Fair Value of $80.79, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Amdocs shares are worth, recalculated every trading day.
$80.79
Gekko Fair Value, Sep 29, 2026
28.9% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open DOX in Gekko
Amdocs insider and Congress trading
No open-market insider purchases were filed for Amdocs, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in DOX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for DOX, plotted on the chart in Gekko.Open DOX in Gekko
Buybacks
Amdocs has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $142.6M
- As a share of market cap
- 2.31%
- Trailing four quarters
- $563.5M
From company filings.
Amdocs earnings: next date and track record
Amdocs reports on Nov 10, 2026, after the close (42 days away), and beat the EPS estimate in 7 of its last 8 reports.
Next earnings report
Nov 10, 2026
Expected after the close, 42 days away
- EPS estimate
- $1.98
- Revenue estimate
- $1.19B
7 of 8reports beat the EPS estimate
±4.4%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, May 13, 2026 AI summary
- What they said
- Amdocs reported solid Q2 fiscal 2026 performance under new CEO Shimie Hortig, who outlined a strategic vision positioning the company as a primary partner for customers in the 'agentic era.' The company is evolving its product portfolio toward agentic automation, including its aOS (agentic operating system for telco). Management emphasized expanding addressable market in telecom and potentially entering new industries through AI-driven transformation.
- Guidance
- Full fiscal year 2026 guidance details to be provided by CFO Tamar Rapaport-Dagim. Management expressed confidence in the agentic opportunity driving future growth, though specific revenue or earnings targets were not disclosed in this excerpt.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 13, 2026 | $1.78 est $1.76 | $1.17B est $1.17B | −0.7% |
| Feb 3, 2026 | $1.81 est $1.76 | $1.16B est $1.15B | −9.8% |
| Nov 11, 2025 | $1.83 est $1.82 | $1.15B est $1.15B | −9.5% |
| Aug 6, 2025 | $1.72 est $1.71 | $1.14B est $1.15B | +4.8% |
| May 7, 2025 | $1.78 est $1.70 | $1.13B est $1.16B | +2.3% |
| Feb 4, 2025 | $1.66 est $1.64 | $1.11B est $1.12B | +0.9% |
| Nov 12, 2024 | $1.70 est $1.70 | $1.26B est $1.26B | −5.5% |
| Aug 7, 2024 | $1.62 est $1.60 | $1.25B est $1.25B | +1.9% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Amdocs stock forecast and analyst price targets
Analysts’ average 12-month price target for Amdocs is $79.25, +38.0% from the last close, from 1 firm rating the stock in the last 90 days.
$79.25consensus 12-month target, +38.0% from the last close
Each firm’s latest rating in the last 90 days: 1 firm.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 7 | Stifel Nicolaus | $71 | +23.7% |
−0.7%average 20-day move after past Accumulation readings
+2.1%average move over the next 20 trading days in the last 5 years
±2.5%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Amdocs seasonality: the next 20 trading days
Over the next 20 trading days from Sep 26, Amdocs averaged +2.1% across the last 5 years, rising in 4 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.7% | 3 of 5 |
| Next 10 trading days | +0.7% | 3 of 5 |
| Next 15 trading days | +1.5% | 4 of 5 |
| Next 20 trading days | +2.1% | 4 of 5 |
| Next 30 trading days | +1.9% | 3 of 5 |
For scale, DOX’s typical 20-trading-day move in either direction is about 4.1%.
Amdocs market cap and key statistics
Amdocs’s market cap is $6.18B, with a P/E ratio of 13.7 and revenue of $4.65B over the last twelve months.
Valuation
- Market cap
- $6.18B
- P/E ratio
- 13.7
- Forward P/E
- 7.1
- EPS, TTM
- $4.21
- Gekko Fair Value
- $80.79
Trading
- Volume
- 700,779
- Avg volume, 20 days
- 884,093
- 52-week high
- $85.63
- 52-week low
- $49.74
- Shares outstanding
- 104.4M
Financials
- Revenue, TTM
- $4.65B
- Profit margin
- 9.8%
- Return on equity
- 13.3%
- Quarterly earnings growth, YoY
- −57.4%
Risk and income
- Beta
- 0.43
- Typical daily move
- ±2.5%
- Typical 20-day move
- ±4.1%
- Dividend yield
- 3.94%
Amdocs stock news this week
2 headlines about Amdocs from the past week, newest first, each linking to the publisher.
- Amdocs stock trades at USD 59.50 as valuation faces pressureAD HOC NEWS, Sep 22
- Why Amdocs (DOX) is a Top Value Stock for the Long-TermZacks Investment Research, Sep 21
Amdocs peers
Amdocs’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| IBMInternational Business Machines | Accumulation | 16.1% below |
| FTNTFortinet | Neutral | 32.5% above |
| NETCloudflare | Neutral | 22.9% above |
| ACNAccenture | Neutral | 9.7% below |
| WDAYWorkday | Neutral | 13.2% above |
| CRDOCredo Technology | Neutral | 19.0% below |
A peer links to its own page where one exists.
Amdocs stock FAQ
What is Amdocs’s market cap?
Amdocs’s market cap is $6.18B at the Sep 28, 2026 close of $57.42, with 104.4M shares outstanding. The shares trade on a P/E ratio of 13.7.
What is the Amdocs stock forecast?
The consensus analyst 12-month price target for Amdocs is $79.25, +38.0% from the last close. Of the 1 firm that rated the stock in the last 90 days, 1 rate it a buy, 0 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Amdocs stock overvalued or undervalued?
On Gekko’s estimate Amdocs is undervalued: the Sep 28, 2026 close of $57.42 is 28.9% below Gekko Fair Value of $80.79. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Amdocs report earnings next?
Amdocs is expected to report on Nov 10, 2026, after the market closes (42 days away). Analysts expect earnings of $1.98 per share on revenue of $1.19B. Amdocs beat the earnings estimate in 7 of its last 8 reports, moving 4.4% on average across the report.
What is Amdocs’s 52-week high and low?
Amdocs’s 52-week high is $85.63 and its 52-week low is $49.74; it closed at $57.42 on Sep 28, 2026, −29.3% over the past year. Over the last five years the shares peaked at $99.75 on Jun 30, 2023.
Is Amdocs stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Amdocs the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.